Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background/Aims: This study examined the risk factors associated with mortality in cirrhotic patients hospitalized with variceal bleeding, and evaluated the effects of acute-on-chronic liver failure (ACLF) on the prognosis of these patients. Methods: This study was retrospectively conducted on patients registered in the Korean acute-on-chronic liver failure study cohort, and on 474 consecutive cirrhotic patients hospitalized with variceal bleeding from January 2013 to December 2013 at 21 university hospitals. ACLF was defined as described by the European Association for the Study of Liver-Chronic Liver Failure Consortium. Results: Among a total of 474 patients, 61 patients were diagnosed with ACLF. The cumulative overall survival (OS) rate was lower in the patients with ACLF than in those without (P<0.001), and patients with higher ACLF grades had a lower OS rate (P<0.001). The chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score was identified as a significant prognostic factor in patients hospitalized with variceal bleeding (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.30–1.50; P<0.001), even in ACLF patients with variceal bleeding (HR, 1.32; 95% CI, 1.19–1.46, P<0.001). Concerning the prediction of the mortality risk at 28- and 90-day using CLIF-SOFA scores, c-statistics were 0.895 (95% CI, 0.829–0.962) and 0.897 (95% CI, 0.842–0.951), respectively, and the optimal cut-off values were 6.5 and 6.5, respectively. Conclusions: In cirrhotic patients hospitalized with variceal bleeding, the prognosis was poor when accompanied by ACLF, especially depending upon CLIF-SOFA score. CLIF-SOFA model well predicted the 28-day or 90-day mortality for cirrhotic patients who experienced variceal bleeding.
Abstract
Background/Aims: This study examined the risk factors associated with mortality in cirrhotic patients hospitalized with variceal bleeding, and evaluated the effects of acute-on-chronic liver failure (ACLF) on the prognosis of these patients. Methods: This study was retrospectively conducted on patients registered in the Korean acute-on-chronic liver failure study cohort, and on 474 consecutive cirrhotic patients hospitalized with variceal bleeding from January 2013 to December 2013 at 21 university hospitals. ACLF was defined as described by the European Association for the Study of Liver-Chronic Liver Failure Consortium. Results: Among a total of 474 patients, 61 patients were diagnosed with ACLF. The cumulative overall survival (OS) rate was lower in the patients with ACLF than in those without (P<0.001), and patients with higher ACLF grades had a lower OS rate (P<0.001). The chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score was identified as a significant prognostic factor in patients hospitalized with variceal bleeding (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.30–1.50; P<0.001), even in ACLF patients with variceal bleeding (HR, 1.32; 95% CI, 1.19–1.46, P<0.001). Concerning the prediction of the mortality risk at 28- and 90-day using CLIF-SOFA scores, c-statistics were 0.895 (95% CI, 0.829–0.962) and 0.897 (95% CI, 0.842–0.951), respectively, and the optimal cut-off values were 6.5 and 6.5, respectively. Conclusions: In cirrhotic patients hospitalized with variceal bleeding, the prognosis was poor when accompanied by ACLF, especially depending upon CLIF-SOFA score. CLIF-SOFA model well predicted the 28-day or 90-day mortality for cirrhotic patients who experienced variceal bleeding.
참고문헌 (37)
- Graham DY, "The course of patients after variceal hemorrhage", Gastroenterology, 80, pp.800~809 (1981)
- D’Amico G, "Pharmacological treatment of portal hypertension : an evidence-based approach", Semin Liver Dis, 19, pp.475~505 (1999)
- 김영대, "Management of Acute Variceal Bleeding", Clinical Endoscopy, 47(4), pp.308~314 (2014), 대한소화기내시경학회
- Villanueva C, "A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding", J Hepatol, 45, pp.560~567 (2006)
- Krige JE, "Variceal recurrence, rebleeding, and survival after endoscopic injection sclerotherapy in 287 alcoholic cirrhotic patients with bleeding esophageal varices", Ann Surg, 244, pp.764~770 (2006)
- Krige JE, "Early rebleeding and death at 6 weeks in alcoholic cirrhotic patients with acute variceal bleeding treated with emergency endoscopic injection sclerotherapy", S Afr J Surg, 47, pp.72~74 (2009)
- Teng W, "Predictors of mortality within 6 weeks after treatment of gastric variceal bleeding in cirrhotic patients", Medicine(Baltimore), 93, pp.e321~ (2014)
- Abraldes JG, "Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy", J Hepatol, 48, pp.229~236 (2008)
- Thomopoulos K, "Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of shortand long-term mortality", Dig Liver Dis, 38, pp.899~904 (2006)
- Chalasani N, "Model for end-stage liver disease(MELD)for predicting mortality in patients with acute variceal bleeding", Hepatology, 35, pp.1282~1284 (2002)
- Wang J, "MELDNa : effective in predicting rebleeding in cirrhosis after cessation of esophageal variceal hemorrhage by endoscopic therapy", J Clin Gastroenterol, 48, pp.870~877 (2014)
- Kim WR, "Hyponatremia and mortality among patients on the livertransplant waiting list", N Engl J Med, 359, pp.1018~1026 (2008)
- Zhao H, "Upper gastrointestinal hemorrhage in acute-on-chronic liver failure : prevalence, characteristics, and impact on prognosis", Expert Rev Gastroenterol Hepatol, 13, pp.263~269 (2019)
- European Association for the Study of the Liver, "EASL clinical practice guidelines for the management of patients with decompensated cirrhosis", J Hepatol, 69, pp.406~460 (2018)
- Kim TY, "Characteristics and discrepancies in acute-on-chronic liver failure : need for a unified definition", PLoS One, 11, pp.e0146745~ (2016)
- Kim TY, "Acute-on-chronic liver failure", Clin Mol Hepatol, 19, pp.349~359 (2013)
- Moreau R, "Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis", Gastroenterology, 144, pp.1426~1437 (2013)
- D’Amico G, "Competing risks and prognostic stages of cirrhosis : a 25-year inception cohort study of 494 patients", Aliment Pharmacol Ther, 39, pp.1180~1193 (2014)
- Suk KT, "Revision and update on clinical practice guideline for liver cirrhosis", Korean J Hepatol, 18, pp.1~21 (2012)
- Sanyal AJ, "Endpoints and clinical trial design for nonalcoholic steatohepatitis", Hepatology, 54, pp.344~353 (2011)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- Hernaez R, "Prevalence and short-term mortality of acute-on-chronic liver failure : a national cohort study from the USA", J Hepatol, 70, pp.639~647 (2019)
- Amitrano L, "Hypoxic hepatitis occurring in cirrhosis after variceal bleeding : still a lethal disease", J Clin Gastroenterol, 46, pp.608~612 (2012)
- Al-Mahtab M, "Influence of variceal bleeding on natural history of ACLF and management options", Hepatol Int, 10, pp.436~439 (2016)
- Saraswathi Arasu, "Incidence and risk factors of dysphagia after variceal band ligation", Clinical and Molecular Hepatology, 25(4), pp.374~380 (2019), 대한간학회
- Cárdenas A, "Renal failure after upper gastrointestinal bleeding in cirrhosis : incidence, clinical course, predictive factors, and short-term prognosis", Hepatology, 34(4 Pt 1), pp.671~676 (2001)
- Peng Y, "Child–Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies", Medicine(Baltimore), 95, pp.e2877~ (2016)
- Blasco-Algora S, "Acute-on-chronic liver failure : pathogenesis, prognostic factors and management", World J Gastroenterol, 21, pp.12125~12140 (2015)
- Wehler M, "Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems", Hepatology, 34, pp.255~261 (2001)
- Stauber RE, "165 evaluation of four prognostic scores in patients with acute-on-chronic liver failure", J Hepatol, 44, pp.S69~S70 (2006)
- Augustin S, "Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding", Am J Gastroenterol, 106, pp.1787~1795 (2011)
- Suk KT, "Hepatic venous pressure gradient : clinical use in chronic liver disease", Clin Mol Hepatol, 20, pp.6~14 (2014)
- Taylor NJ, "The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality", Aliment Pharmacol Ther, 40, pp.705~715 (2014)
- Wasmuth HE, "Patients with acute on chronic liver failure display"sepsis-like"immune paralysis", J Hepatol, 42, pp.195~201 (2005)
- Guillermo Nahúm López-Sánchez, "The fibrogenic process and the unleashing of acute-on-chronic liver failure", Clinical and Molecular Hepatology, 26(1), pp.7~15 (2020), 대한간학회
- Gustot T, "Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis", Hepatology, 62, pp.243~252 (2015)
- Keiji Yokoyama, "Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal", gastric varices in Child-Pugh class C end-stage liver cirrhosis, 2019, pp.25(2), 183~189[DOI]
